Selected research
Industry Research
Dengue Fever Testing Industry Research Report 2026
Market perspective
The global Dengue Fever Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Dengue Fever Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Dengue Fever Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Dengue Fever Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Dengue Fever Testing include Quest Diagnostics, Certest Biotec, OriGene Technologies, Thermo Fisher, Abnova, Roche Molecular Systems, Abbott Laboratories, InBios International and NovaTec Immundiagnostica and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Dengue Fever Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Dengue Fever Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dengue Fever Testing Market by Company
Quest Diagnostics
Certest Biotec
OriGene Technologies
Thermo Fisher
Abnova
Roche Molecular Systems
Abbott Laboratories
InBios International
NovaTec Immundiagnostica
Sub.PerkinElmer
Dengue Fever Testing Segment by Type
ELISA-Based Tests
RT-PCR Based Tests
Dengue IgG/IgM Rapid Test
Dengue Fever Testing Segment by Application
Hospitals
Public Health Laboratory
Diagnostic Centers
Others
Dengue Fever Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dengue Fever Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dengue Fever Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dengue Fever Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dengue Fever Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA-Based Tests
- RT-PCR Based Tests
- Dengue IgG/IgM Rapid Test
Applications
- Hospitals
- Public Health Laboratory
- Diagnostic Centers
- Others
Companies covered
- Quest Diagnostics
- Certest Biotec
- OriGene Technologies
- Thermo Fisher
- Abnova
- Roche Molecular Systems
- Abbott Laboratories
- InBios International
- NovaTec Immundiagnostica
- Sub.PerkinElmer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Dengue Fever Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 ELISA-Based Tests
- 2.2.3 RT-PCR Based Tests
- 2.2.4 Dengue IgG/IgM Rapid Test
- 2.3 Dengue Fever Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Public Health Laboratory
- 2.3.4 Diagnostic Centers
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Dengue Fever Testing Breakdown Data by Type
- 3.1 Global Dengue Fever Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Dengue Fever Testing Forecasted Market Size by Type (2027-2032)
4 Dengue Fever Testing Breakdown Data by Application
- 4.1 Global Dengue Fever Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Dengue Fever Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Dengue Fever Testing Market Perspective (2021-2032)
- 5.2 Global Dengue Fever Testing Growth Trends by Region
- 5.2.1 Global Dengue Fever Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Dengue Fever Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Dengue Fever Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Dengue Fever Testing Market Dynamics
- 5.3.1 Dengue Fever Testing Industry Trends
- 5.3.2 Dengue Fever Testing Market Drivers
- 5.3.3 Dengue Fever Testing Market Challenges
- 5.3.4 Dengue Fever Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Dengue Fever Testing Players by Revenue
- 6.1.1 Global Top Dengue Fever Testing Players by Revenue (2021-2026)
- 6.1.2 Global Dengue Fever Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Dengue Fever Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Dengue Fever Testing Head Office and Area Served
- 6.4 Global Dengue Fever Testing Players, Product Type & Application
- 6.5 Global Dengue Fever Testing Manufacturers Established Date
- 6.6 Global Dengue Fever Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Dengue Fever Testing Market Size (2021-2032)
- 7.2 North America Dengue Fever Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Dengue Fever Testing Market Size by Country (2021-2026)
- 7.4 North America Dengue Fever Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Dengue Fever Testing Market Size (2021-2032)
- 8.2 Europe Dengue Fever Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Dengue Fever Testing Market Size by Country (2021-2026)
- 8.4 Europe Dengue Fever Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Dengue Fever Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Dengue Fever Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Dengue Fever Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Dengue Fever Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Dengue Fever Testing Market Size (2021-2032)
- 10.2 South America Dengue Fever Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Dengue Fever Testing Market Size by Country (2021-2026)
- 10.4 South America Dengue Fever Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Dengue Fever Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Dengue Fever Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Dengue Fever Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Dengue Fever Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Quest Diagnostics
- 12.1.1 Quest Diagnostics Company Information
- 12.1.2 Quest Diagnostics Business Overview
- 12.1.3 Quest Diagnostics Revenue in Dengue Fever Testing Business (2021-2026)
- 12.1.4 Quest Diagnostics Dengue Fever Testing Product Portfolio
- 12.1.5 Quest Diagnostics Recent Developments
- 12.2 Certest Biotec
- 12.2.1 Certest Biotec Company Information
- 12.2.2 Certest Biotec Business Overview
- 12.2.3 Certest Biotec Revenue in Dengue Fever Testing Business (2021-2026)
- 12.2.4 Certest Biotec Dengue Fever Testing Product Portfolio
- 12.2.5 Certest Biotec Recent Developments
- 12.3 OriGene Technologies
- 12.3.1 OriGene Technologies Company Information
- 12.3.2 OriGene Technologies Business Overview
- 12.3.3 OriGene Technologies Revenue in Dengue Fever Testing Business (2021-2026)
- 12.3.4 OriGene Technologies Dengue Fever Testing Product Portfolio
- 12.3.5 OriGene Technologies Recent Developments
- 12.4 Thermo Fisher
- 12.4.1 Thermo Fisher Company Information
- 12.4.2 Thermo Fisher Business Overview
- 12.4.3 Thermo Fisher Revenue in Dengue Fever Testing Business (2021-2026)
- 12.4.4 Thermo Fisher Dengue Fever Testing Product Portfolio
- 12.4.5 Thermo Fisher Recent Developments
- 12.5 Abnova
- 12.5.1 Abnova Company Information
- 12.5.2 Abnova Business Overview
- 12.5.3 Abnova Revenue in Dengue Fever Testing Business (2021-2026)
- 12.5.4 Abnova Dengue Fever Testing Product Portfolio
- 12.5.5 Abnova Recent Developments
- 12.6 Roche Molecular Systems
- 12.6.1 Roche Molecular Systems Company Information
- 12.6.2 Roche Molecular Systems Business Overview
- 12.6.3 Roche Molecular Systems Revenue in Dengue Fever Testing Business (2021-2026)
- 12.6.4 Roche Molecular Systems Dengue Fever Testing Product Portfolio
- 12.6.5 Roche Molecular Systems Recent Developments
- 12.7 Abbott Laboratories
- 12.7.1 Abbott Laboratories Company Information
- 12.7.2 Abbott Laboratories Business Overview
- 12.7.3 Abbott Laboratories Revenue in Dengue Fever Testing Business (2021-2026)
- 12.7.4 Abbott Laboratories Dengue Fever Testing Product Portfolio
- 12.7.5 Abbott Laboratories Recent Developments
- 12.8 InBios International
- 12.8.1 InBios International Company Information
- 12.8.2 InBios International Business Overview
- 12.8.3 InBios International Revenue in Dengue Fever Testing Business (2021-2026)
- 12.8.4 InBios International Dengue Fever Testing Product Portfolio
- 12.8.5 InBios International Recent Developments
- 12.9 NovaTec Immundiagnostica
- 12.9.1 NovaTec Immundiagnostica Company Information
- 12.9.2 NovaTec Immundiagnostica Business Overview
- 12.9.3 NovaTec Immundiagnostica Revenue in Dengue Fever Testing Business (2021-2026)
- 12.9.4 NovaTec Immundiagnostica Dengue Fever Testing Product Portfolio
- 12.9.5 NovaTec Immundiagnostica Recent Developments
- 12.10 Sub.PerkinElmer
- 12.10.1 Sub.PerkinElmer Company Information
- 12.10.2 Sub.PerkinElmer Business Overview
- 12.10.3 Sub.PerkinElmer Revenue in Dengue Fever Testing Business (2021-2026)
- 12.10.4 Sub.PerkinElmer Dengue Fever Testing Product Portfolio
- 12.10.5 Sub.PerkinElmer Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst